Seladelpar lysine is a salt and hydrate form of seladelpar, an orally bioavailable agonist of peroxisome proliferator-activated receptor delta (PPARδ). It is primarily used as an active pharmaceutical ingredient in pharmaceutical manufacturing, with research applications in conditions involving bile acid regulation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Seladelpar lysine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Seladelpar
pharmaceutical raw material
Elinzanetant
pharmaceutical raw material
Gadoterate meglumine
pharmaceutical raw material
Guaifenesin
pharmaceutical raw material
(RS)-methoxyphenamine
pharmaceutical raw material
(2S)-2,6-diaminohexanoic acid;2-[4-[(2R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]sulfanyl-2-methylphenoxy]acetic acid;dihydrate
WTKSWPYGZDCUNQ-JZXFCXSPSA-N
CCO[C@H](COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC(=C(C=C2)OCC(=O)O)C.C(CCN)C[C@@H](C(=O)O)N.O.O
Sourcing Seladelpar lysine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.